This is the library for the Enduring Materials from the Targets for Cancer IO: A Deep Dive, TCR based therapies webinar that was conducted on December 7, 2022.
Targets for Cancer IO: A Deep Dive Series 2 is supported, in part, by educational grants from:Interested in supporting this program? The SITC Development team would love to work with you. Contact Development@sitcancer.org for more information on how your organization's support can help advance cancer immunotherapy and make "cure" a reality.
#ClinicalTrials#Tcells#RecordedWebinar#TargetsforCancerImmunotherapyADeepDiveSeminarSeries#Industry#Clinician#Oncologist#Researcher#2022
Meeting: 2022 Targets in Cancer IO: A Deep Dive in TCR based Therapies; Moderator: Harlan Robins, PhD – Adaptive Biotechnologies Corporation; Faculty: David Berman, MD, PhD - Immunocore,Aude Chapuis, MD - Fred Hutchinson Cancer Center, Ira Mellman, PhD - Genentech01:59:30